4//SEC Filing
Chimovits Erez 4
Accession 0000950170-24-114685
CIK 0002022626other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:15 PM ET
Size
5.9 KB
Accession
0000950170-24-114685
Insider Transaction Report
Form 4
Chimovits Erez
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-10-10+17,096→ 17,096 totalExercise: $17.00Exp: 2034-10-09→ Common Stock (17,096 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest upon the earlier of (i) October 10, 2025, and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
- [F2]Pursuant to an agreement with OrbiMed Advisors LLC, OrbiMed Capital GP VIII LLC, OrbiMed Israel GP II, L.P., and OrbiMed Advisors Israel II Limited, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, OrbiMed Capital GP VIII LLC, OrbiMed Israel GP II, L.P., and OrbiMed Advisors Israel II Limited, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VIII, LP and OrbiMed Israel Partners II, L.P.
Documents
Issuer
Upstream Bio, Inc.
CIK 0002022626
Entity typeother
Related Parties
1- filerCIK 0001706399
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 4:15 PM ET
- Size
- 5.9 KB